Electrolyte disorders are ERAS-associated in patients undergoing hepato-pancreato-biliary surgery.


Journal

Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 29 04 2020
accepted: 28 06 2020
pubmed: 28 7 2020
medline: 20 7 2021
entrez: 26 7 2020
Statut: ppublish

Résumé

Emerging evidences have raised concerns about electrolyte disorders caused by restrictive fluid management in the enhanced recovery after surgery (ERAS) protocol. This study aims to investigate the morbidity and treatment of electrolyte disorders associated with ERAS in patients undergoing hepato-pancreato-biliary (HPB) surgery. Clinical data from 157 patients under the ERAS program and 166 patients under the traditional (Non-ERAS) program after HPB surgery were retrospectively analyzed. Risk factors and predictive factors of postoperative electrolyte disorders were analyzed by logistic regression analysis and receiver operator characteristic (ROC) curve analysis, respectively. The average of intravenous fluid, sodium, chloride, and potassium supplementation after surgery were significantly lower in the ERAS group. Hypokalemia was the most common type of electrolyte disorders in the ERAS group, whose incidence was substantially increased compared to that in the Non-ERAS group [28.77% vs. 8.97%, p < 0.001, on postoperative (POD) 5]. Logistic regression analysis identified the ERAS program and age as independent risk factors of hypokalemia. ROC curve analysis identified serum potassium levels below 3.76 mmol/L on POD 3 (area under curve 0.731, sensitivity 58.54%, specificity 82.69%) as a predictive factor for postoperative hypokalemia in ERAS patients. Oral supplementation at an average of 35.41 mmol potassium per day was effective in restoring the ERAS-associated hypokalemia. ERAS procedures were particularly associated with a lower supplementation of potassium and a higher incidence of hypokalemia in patients after HPB surgery. Oral potassium supplementation could be an adopted ERAS program for the elderly undergoing HPB surgery.

Identifiants

pubmed: 32710380
doi: 10.1007/s00423-020-01922-y
pii: 10.1007/s00423-020-01922-y
doi:

Substances chimiques

Potassium RWP5GA015D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

603-611

Subventions

Organisme : the Guangzhou City Science and Technology Program
ID : 201400000001-3 and 262-1
Organisme : the Guangdong Province Science and Technology Program
ID : 2017A030313684
Organisme : Dean Foundation of Nanfang Hospital, Southern Medical University
ID : 2018C029
Organisme : National Natural Science Foundation of China
ID : 81600462

Auteurs

Hongxian Peng (H)

Division of Hepatobiliopancreatic Surgery, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

Qifan Zhang (Q)

Division of Hepatobiliopancreatic Surgery, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

Jianping Qian (J)

Division of Hepatobiliopancreatic Surgery, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

Fangyi Ruan (F)

The First Clinical College, Southern Medical University, Guangzhou, Guangdong, China.

Hanwen Mai (H)

The First Clinical College, Southern Medical University, Guangzhou, Guangdong, China.

Zehao Wang (Z)

The First Clinical College, Southern Medical University, Guangzhou, Guangdong, China.

Meiqi Liu (M)

The First Clinical College, Southern Medical University, Guangzhou, Guangdong, China.

Zihuan Wang (Z)

The First Clinical College, Southern Medical University, Guangzhou, Guangdong, China.

Hao Chen (H)

Division of Hepatobiliopancreatic Surgery, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

Jieyuan Li (J)

Division of Hepatobiliopancreatic Surgery, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

Bili Zhu (B)

Huiqiao Medical Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

Chuanjiang Li (C)

Division of Hepatobiliopancreatic Surgery, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. licj@smu.edu.cn.

Kai Wang (K)

Division of Hepatobiliopancreatic Surgery, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. kaiwang@smu.edu.cn.

Jie Zhou (J)

Division of Hepatobiliopancreatic Surgery, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. jacky@smu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH